United States Biotechnology & Medical Research

Histogen Inc (HSTO)

Track

Stock chart
Ticker: HSTO Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Pascoe Richard W
President, CEO & Director
1 purchase — total 22,800 USD
Buy 30 Mar 2021
Value US$4,281,470.44 | Price 261.27 | Shares 88,183
Buy 3 Dec 2020
Value US$3,741,495.07 | Price 289.08 | Shares 20,472
Buy 8 Apr 2015
Value US$23,000.00 | Price 5.75 | Shares 4,000
Buy 30 Jul 2013
Value US$1,363,450.00 | Price 11.00 | Shares 123,950
Buy 30 Jul 2013
Value US$1,817,915.00 | Price 11.00 | Shares 165,265
Buy 30 Jul 2013
Value US$2,090,594.00 | Price 11.00 | Shares 190,054
Sale 30 Jul 2013
Value US$5,885.00 | Price 11.00 | Shares 535
Buy 30 Jul 2013
Value US$27,170.00 | Price 11.00 | Shares 2,470
Sale 30 Jul 2013
Value US$154.00 | Price 11.00 | Shares 14
Buy 30 Jul 2013
Value US$1,154,472.00 | Price 11.00 | Shares 104,952
Sale 30 Jul 2013
Value US$6,072.00 | Price 11.00 | Shares 552
Buy 30 Jul 2013
Value US$1,820,775.00 | Price 11.00 | Shares 165,525
Sale 30 Jul 2013
Value US$3,872.00 | Price 11.00 | Shares 352
Buy 30 Jul 2013
Value US$1,817,915.00 | Price 11.00 | Shares 165,265
Buy 30 Jul 2013
Value US$1,820,775.00 | Price 11.00 | Shares 165,525
Sale 30 Jul 2013
Value US$3,872.00 | Price 11.00 | Shares 352
Buy 30 Jul 2013
Value US$2,090,594.00 | Price 11.00 | Shares 190,054
Sale 30 Jul 2013
Value US$5,885.00 | Price 11.00 | Shares 535
Buy 30 Jul 2013
Value US$1,817,915.00 | Price 11.00 | Shares 165,265
Buy 30 Jul 2013
Value US$27,170.00 | Price 11.00 | Shares 2,470
Sale 30 Jul 2013
Value US$154.00 | Price 11.00 | Shares 14
Buy 30 Jul 2013
Value US$1,154,472.00 | Price 11.00 | Shares 104,952
Sale 30 Jul 2013
Value US$6,072.00 | Price 11.00 | Shares 552
Buy 30 Jul 2013
Value US$28,468.00 | Price 11.00 | Shares 2,588
Buy 30 Jul 2013
Value US$151,800.00 | Price 11.00 | Shares 13,800
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-03-30 2021-03-30 B Purchase
3.5
Pascoe Richard W

President, CEO & Director

Executive Director
88,183 -29.7%
261.27
US$4,281,470 		88,183 -29.7% 261.27 US$4,281,470
2020-12-07 2020-12-03 B Purchase
3.5
Pascoe Richard W

President, CEO & Director

Executive Director
20,472 +42.8%
289.08
US$3,741,495 		20,472 +42.8% 289.08 US$3,741,495
2015-04-10 2015-04-08 B Purchase KISNER DANIEL L Non-Executive Director
12,267 +2.7%
157.62
US$2,068,000 		12,267 +2.7% 157.62 US$2,068,000
2013-08-01 2013-07-30 B Purchase LACASSE LOUIS P Non-Executive Director
123,950 +18.1%
11.00
US$1,363,450 		123,950 +18.1% 11.00 US$1,363,450
2013-08-01 2013-07-30 B Purchase Scopa James Paul Non-Executive Director
165,265 +16.1%
11.00
US$1,817,915 		165,265 +16.1% 11.00 US$1,817,915
2013-08-01 2013-07-30 B Purchase ADVENT VENTURE PARTNERS LLP Large shareholder
190,054 +9.6%
11.00
US$2,090,594 		190,054 +9.6% 11.00 US$2,090,594
2013-08-01 2013-07-30 S Sale ADVENT VENTURE PARTNERS LLP Large shareholder
535 -0.0%
11.00
US$5,885 		535 -0.0% 11.00 US$5,885
2013-08-01 2013-07-30 B Purchase Aberdare GP III, L.L.C. Large shareholder
2,470 +4.9%
11.00
US$27,170 		2,470 +4.9% 11.00 US$27,170
2013-08-01 2013-07-30 S Sale Aberdare GP III, L.L.C. Large shareholder
14 -0.0%
11.00
US$154 		14 -0.0% 11.00 US$154
2013-08-01 2013-07-30 B Purchase Aberdare GP III, L.L.C. Large shareholder
104,952 +4.9%
11.00
US$1,154,472 		104,952 +4.9% 11.00 US$1,154,472
2013-08-01 2013-07-30 S Sale Aberdare GP III, L.L.C. Large shareholder
552 -0.0%
11.00
US$6,072 		552 -0.0% 11.00 US$6,072
2013-08-01 2013-07-30 B Purchase COOPERATIVE GILDE HEALTHCARE II U.A. Large shareholder
165,525 +12.5%
11.00
US$1,820,775 		165,525 +12.5% 11.00 US$1,820,775
2013-08-01 2013-07-30 S Sale COOPERATIVE GILDE HEALTHCARE II U.A. Large shareholder
352 -0.0%
11.00
US$3,872 		352 -0.0% 11.00 US$3,872
2013-08-01 2013-07-30 B Purchase MPM BioVentures IV QP LP Large shareholder
165,265 +16.1%
11.00
US$1,817,915 		165,265 +16.1% 11.00 US$1,817,915
2013-08-01 2013-07-30 B Purchase Perret Marc Olivier Non-Executive Director Large shareholder
165,525 +12.5%
11.00
US$1,820,775 		165,525 +12.5% 11.00 US$1,820,775
2013-08-01 2013-07-30 S Sale Perret Marc Olivier Non-Executive Director Large shareholder
352 -0.0%
11.00
US$3,872 		352 -0.0% 11.00 US$3,872
2013-08-01 2013-07-30 B Purchase Malik Shahzad Non-Executive Director Large shareholder
190,054 +9.6%
11.00
US$2,090,594 		190,054 +9.6% 11.00 US$2,090,594
2013-08-01 2013-07-30 S Sale Malik Shahzad Non-Executive Director Large shareholder
535 -0.0%
11.00
US$5,885 		535 -0.0% 11.00 US$5,885
2013-08-01 2013-07-30 B Purchase EVNIN LUKE Large shareholder
165,265 +16.1%
11.00
US$1,817,915 		165,265 +16.1% 11.00 US$1,817,915
2013-08-01 2013-07-30 B Purchase KLINGENSTEIN PAUL H Non-Executive Director Large shareholder
2,470 +4.9%
11.00
US$27,170 		2,470 +4.9% 11.00 US$27,170
2013-08-01 2013-07-30 S Sale KLINGENSTEIN PAUL H Non-Executive Director Large shareholder
14 -0.0%
11.00
US$154 		14 -0.0% 11.00 US$154
2013-08-01 2013-07-30 B Purchase KLINGENSTEIN PAUL H Non-Executive Director Large shareholder
104,952 +4.9%
11.00
US$1,154,472 		104,952 +4.9% 11.00 US$1,154,472
2013-08-01 2013-07-30 S Sale KLINGENSTEIN PAUL H Non-Executive Director Large shareholder
552 -0.0%
11.00
US$6,072 		552 -0.0% 11.00 US$6,072
2013-08-01 2013-07-30 B Purchase HALE DAVID F Non-Executive Director
2,588 +1.8%
11.00
US$28,468 		2,588 +1.8% 11.00 US$28,468
2013-08-01 2013-07-30 B Purchase Mento Steven J

President, CEO & Director

Executive Director
13,800 +3.7%
11.00
US$151,800 		13,800 +3.7% 11.00 US$151,800
Explore more

More insider trading research around Histogen Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America